April 24, 2019 Artoss, Inc. is pleased to announce that the US Food & Drug Administration has cleared NanoBone SBX Putty for standalone use in posterolateral spinal fusion. NanoBone was tested alone (without addition of autograft or bone marrow aspirate) in the ASTM International standardized animal model and found to be equivalent to the “gold …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone